A stabilized mRNA carrier turns tumor injection into broader immune activation by extending vaccine delivery to lymph nodes and the spleen.

With the introduction of mRNA vaccines in the 2010s – vaccines that use messenger RNA molecules in cells to train the body to fight dangerous invaders – doctors found a promising new tool in the fight against the disease. Now some say they’ve gotten a step closer to stopping cancer in its tracks.

The mRNA-based Covid vaccines helped blunt the impact of the pandemic but also sparked political backlash that has threatened to slow or derail dozens of potential cancer treatments. Now there are signs that the mRNA train is still on track.

Nearly all of the patients who responded to the a personalized mRNA pancreatic vaccine are still alive six years later.

Scientists could soon develop personalized cancer vaccines.

Northwest Biotherapeutics, Inc. (OTCQB:NWBO) (the "Company" or "NWBio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today announced the appointment of Annalisa Jenkins,

Dr. Nicole Saphier is President Donald Trump's new pick for U.S. surgeon general, so we're looking into what she's said on different health topics.

Only 30% of more than 6500 survey respondents received all 3 vaccines as recommended. Fewer than one-third of adults aged 50 years and older with cancer were vaccinated against influenza, pneumococcus,